Ovid Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $13.2M | $26.3M | $27.0M | $44.9M | $187.8M | $72.0M | $41.9M | $36.5M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $74.4M | $55.9M | $109.6M | $131.4M | $190.5M | $74.8M | $79.8M | $44.3M |
| Property, Plant & Equipment | $252.0K | $433.0K | $769.0K | $1.1M | $242.8K | $135.6K | $68.4K | $69.9K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $0 | $100.0K | $200.0K | $222.1K | $164.1K | $319.0K | $467.0K | $392.0K |
| Total Assets | $150.9M | $92.2M | $144.0M | $155.3M | $194.5M | $75.9M | $80.8M | $47.6M |
| Liabilities | ||||||||
| Accounts Payable | $2.0M | $3.2M | $3.7M | $2.0M | $7.1M | $5.4M | $3.3M | $3.8M |
| Total Current Liabilities | $8.3M | $10.5M | $11.5M | $7.0M | $14.8M | $22.1M | $10.5M | $8.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $20.3M | $23.9M | $56.2M | $23.0M | $14.8M | $32.3M | $10.8M | $8.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-321.7M | $-304.3M | $-277.9M | $-225.5M | $-171.4M | $-294.2M | $-213.2M | $-152.7M |
| Total Stockholders' Equity | $130.7M | $68.2M | $87.8M | $132.3M | $179.7M | $43.6M | $70.0M | $38.8M |